FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers biotechnology and medicine. What is described is an immunogen for inducing the IgE immune response. The immunogen contains at least one IgE antigen peptide bound to an immunogenic carrier. The immunogenic carriers may be presented by virus-like particles specified in a group consisting of HBcAg, HBsAg and Qbeta VLP There are also disclosed compositions and method for preventing, relieving or treating an IgE-associated disorder in an individual with using the above immunogen.
EFFECT: group of inventions may be used in medicine for treating the allergic diseases.
20 cl, 2 dwg, 13 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PCSK9 VACCINE | 2010 |
|
RU2538162C2 |
| ANTIGEN TAU-PEPTIDES AND THEIR APPLICATION | 2010 |
|
RU2518291C2 |
| CONJUGATES OF PEPTIDE Melan-A, VIRUS-LIKE PARTICLE ANALOGUE | 2004 |
|
RU2351362C2 |
| STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF | 2015 |
|
RU2688831C2 |
| STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF | 2015 |
|
RU2743793C1 |
| IMMUNOGENIC COMPOSITION, VACCINE COMPRISING SAME, KIT FOR PREPARING SAID COMPOSITION AND METHOD OF TREATING DISEASES ASSOCIATED WITH GASTRIN SECRETION PATHOLOGY | 2014 |
|
RU2664197C2 |
| SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2005 |
|
RU2393223C2 |
| VIRUS-LIKE PARTICLES COMPOSITION | 2013 |
|
RU2705301C2 |
| ANTIGEN MOLECULAR MASSIFS | 2003 |
|
RU2324704C2 |
| IMMUNOREGULATORY VACCINE | 2013 |
|
RU2650709C2 |
